Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts
Rosengard, A.M.; Cary, N.; Horsley, J.; Belcher, C.; Langford, G.; Cozzi, E.; Wallwork, J.; White, D.J.
Transplantation Proceedings 27(1): 326-327
1995
ISSN/ISBN: 0041-1345 PMID: 7533400 Document Number: 445476
Document emailed within 1 workday
Related Documents
Cary, N.; Moody, J.; Yannoutsos, N.; Wallwork, J.; White, D. 1993: Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection Transplantation Proceedings 25(1 Pt 1): 400-401Shibata, T.; Cosio, F.G.; Birmingham, D.J. 1991: Complement activation induces the expression of decay-accelerating factor on human mesangial cells Journal of Immunology 147(11): 3901-3908
Ramirez, P.; Chavez, R.; Majado, M.; Munitiz, V.; Muñoz, A.; Hernandez, Q.; Palenciano, C.G.; Pino-Chavez, G.; Loba, M.; Minguela, A.; Yelamos, J.; Gago, M.R.; Vizcaino, A.S.; Asensi, H.; Cayuela, M.G.; Segura, B.; Marin, F.; Rubio, A.; Fuente, T.; Robles, R.; Bueno, F.S.; Sansano, T.; Acosta, F.; Rodriguez, J.M.; Navarro, F.; Cabezuelo, J.; Cozzi, E.; White, D.J.; Calne, R.Y.; Parrilla, P. 2000: Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days Transplantation 70(7): 989-998
Post, T.W.; Arce, M.A.; Liszewski, M.K.; Thompson, E.S.; Atkinson, J.P.; Lublin, D.M. 1990: Structure of the gene for human complement protein decay accelerating factor Journal of Immunology 144(2): 740-744
Coyne, K.E.; Hall, S.E.; Thompson, S.; Arce, M.A.; Kinoshita, T.; Fujita, T.; Anstee, D.J.; Rosse, W.; Lublin, D.M. 1992: Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor Journal of Immunology 149(9): 2906-2913
Iwata, K.; Seya, T.; Ariga, H.; Nagasawa, S. 1994: Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein Journal of Immunology 152(7): 3436-3444
Pearce, E.J.; Hall, B.F.; Sher, A. 1990: Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor Journal of Immunology 144(7): 2751-2756
Richards, A.C.; Tucker, A.W.; Carrington, C.A.; White, D.J. 1996: Reduced human neutrophil adhesion to porcine endothelia expressing human decay accelerating factor Transplantation Proceedings 28(2): 636
Nicholson-Weller, A.; Burge, J.; Fearon, D.T.; Weller, P.F.; Austen, K.F. 1982: Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system Journal of Immunology 129(1): 184-189
Shibuya, K.; Abe, T.; Fujita, T. 1992: Decay-accelerating factor functions as a signal transducing molecule for human monocytes Journal of Immunology 149(5): 1758-1762
Quigg, R.J.; Nicholson-Weller, A.; Cybulsky, A.V.; Badalamenti, J.; Salant, D.J. 1989: Decay accelerating factor regulates complement activation on glomerular epithelial cells Journal of Immunology 142(3): 877-882
Kammer, G.M.; Walter, E.I.; Medof, M.E. 1988: Association of cytoskeletal re-organization with capping of the complement decay-accelerating factor on T lymphocytes Journal of Immunology 141(9): 2924-2928
Higgins, P.J.; Ko, J.L.; Lobell, R.; Sardonini, C.; Alessi, M.K.; Yeh, C.G. 1997: A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities Journal of Immunology 158(6): 2872-2881
Lesnikoski, B.A.; Shaffer, D.A.; Van der Werf, W.J.; Dalmasso, A.P.; Soares, M.P.; Latinne, D.; Bazin, H.; Hancock, W.W.; Bach, F.H. 1995: Endothelial and host mononuclear cell activation and cytokine expression during rejection of pig-to-baboon discordant xenografts Transplantation Proceedings 27(1): 290-291
Schmid, E.; Müller, T.H.; Budzinski, R.M.; Pfizenmaier, K.; Binder, K. 1995: Lymphocyte adhesion to human endothelial cells induces tissue factor expression via a juxtacrine pathway Thrombosis and Haemostasis 73(3): 421-428
Eligini, S.; Banfi, C.; Brambilla, M.; Camera, M.; Barbieri, S.S.; Poma, F.; Tremoli, E.; Colli, S. 2002: 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade Thrombosis and Haemostasis 88(3): 524-532
Mulder, L.C.; Mora, M.; Lazzeri, M.; Boschi, M.; Ciccopiedi, E.; Melli, C.; Bruzzone, P.; Alfani, D. 1996: Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model Transplantation Proceedings 28(2): 589
Morello, D.; Asselin, C.; Lavenu, A.; Marcu, K.B.; Babinet, C. 1989: Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice Oncogene 4(8): 955-961
Mulder, L.C.; Mora, M.; Lazzeri, M.; Boschi, M.; Ciccopiedi, E.; Marinucci, G.; Melli, C.M.; Bruzzone, P.; Alfani, D.; Cortesini, R.; Rossini, M. 1996: Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF Transplantation Proceedings 28(1): 127-129
Choi-Miura, N.H. 1999: Decay-accelerating factor (DAF; CD55) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 79-81